Literature DB >> 15128924

Association of maternal histocompatibility at class II HLA loci with maternal microchimerism in the fetus.

Stanley M Berry1, Sonia S Hassan, Evelyne Russell, Debra Kukuruga, Susan Land, Joseph Kaplan.   

Abstract

For investigating the possible influence of maternal-fetal HLA compatibility on maternal microchimerism, DNA samples from blood of 120 maternal-fetal pairs were genotyped at two polymorphic loci: glutathione-S-transferase M1 (GSTM1) and angiotensin-converting enzyme (ACE). Informative pairs (mother heterozygous/fetus homozygous at one of the two loci) were then tested by quantitative real-time PCR for the noninherited maternal allele(s) and genotyped at the HLA-A, B, and C class I loci and/or at the DRB1 and/or DQB1 class II loci. Small numbers of maternal cells were detected in the circulation of 16 of the 30 informative second- and third-trimester fetuses. Comparison with HLA data suggested an association between microchimerism and maternal compatibility at the class II DRB1 and/or DQB1 HLA loci and with the maternal HLA-DQB1*0301 allele. There was no relationship between maternal microchimerism and maternal-fetal HLA compatibility at other HLA loci or with gestational age, fetal anomalies, or red cell or platelet isoimmunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128924     DOI: 10.1203/01.PDR.0000129656.10005.A6

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jung-Sun Kim; Ji Young Park; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2011-09-27       Impact factor: 3.886

2.  Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant.

Authors:  Sami B Kanaan; Hilary S Gammill; Whitney E Harrington; Stephen C De Rosa; Philip A Stevenson; Alexandra M Forsyth; Judy Allen; Emma Cousin; Koen van Besien; Colleen S Delaney; J Lee Nelson
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

3.  Increased maternal microchimerism after open fetal surgery.

Authors:  Payam Saadai; Tippi C MacKenzie
Journal:  Chimerism       Date:  2012-07-01

Review 4.  Maternal-fetal cellular trafficking: clinical implications and consequences.

Authors:  Cerine Jeanty; S Christopher Derderian; Tippi C Mackenzie
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

Review 5.  Immunological implications of pregnancy-induced microchimerism.

Authors:  Jeremy M Kinder; Ina A Stelzer; Petra C Arck; Sing Sing Way
Journal:  Nat Rev Immunol       Date:  2017-05-08       Impact factor: 53.106

6.  Maternal HLA class II compatibility in men with systemic lupus erythematosus.

Authors:  Anne M Stevens; Betty P Tsao; Bevra H Hahn; Katherine Guthrie; Nathalie C Lambert; Allison J Porter; Tracy S Tylee; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2005-09

Review 7.  The otherness of self: microchimerism in health and disease.

Authors:  J Lee Nelson
Journal:  Trends Immunol       Date:  2012-05-19       Impact factor: 16.687

8.  Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?

Authors:  Roberto Romero; Amy Whitten; Steven J Korzeniewski; Nandor Gabor Than; Piya Chaemsaithong; Jezid Miranda; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Reprod Immunol       Date:  2013-08-01       Impact factor: 3.886

Review 9.  Fetal Microchimerism in Cancer Protection and Promotion: Current Understanding in Dogs and the Implications for Human Health.

Authors:  Jeffrey N Bryan
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

Review 10.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.